These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 23063839
1. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel. Levine H, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Zarka S, Balicer RD. Vaccine; 2012 Nov 26; 30(50):7260-4. PubMed ID: 23063839 [Abstract] [Full Text] [Related]
2. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel. Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD. Hum Vaccin Immunother; 2015 Nov 26; 11(6):1400-5. PubMed ID: 25891446 [Abstract] [Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
4. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF. Vaccine; 2013 Dec 17; 32(1):69-73. PubMed ID: 24188751 [Abstract] [Full Text] [Related]
5. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program. Wang IJ, Hwang KC, Tsai YH, Wu YN, Chao SJ, Chen TE, Huang LM. Acta Paediatr Taiwan; 2006 Dec 17; 47(1):14-7. PubMed ID: 17016964 [Abstract] [Full Text] [Related]
6. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel. Cohen D, Muhsen Kh, Aboudy Y, Harari H, Mendelson E, Green MS. Vaccine; 2006 Jul 07; 24(27-28):5604-8. PubMed ID: 16716460 [Abstract] [Full Text] [Related]
7. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Epidemiol Infect; 2011 Apr 07; 139(4):494-504. PubMed ID: 20587123 [Abstract] [Full Text] [Related]
8. Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison. Huerta M, Davidovitch N, Ankol OE, Zaaide Y, Grotto I, Balicer RD, Zangvil E. Prev Med; 2004 Dec 07; 39(6):1223-6. PubMed ID: 15539059 [Abstract] [Full Text] [Related]
9. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL. J Microbiol Immunol Infect; 2005 Jun 07; 38(3):169-75. PubMed ID: 15986066 [Abstract] [Full Text] [Related]
11. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign. Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA. BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601 [Abstract] [Full Text] [Related]
19. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact. Wang IJ, Huang LM, Chen HH, Hwang KC, Chen CJ. J Med Virol; 2007 Jan 08; 79(1):97-103. PubMed ID: 17133552 [Abstract] [Full Text] [Related]
20. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C. Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]